View in EDS HTML Full Text PDF Full Text

CD11c+ B cells in relapsing–remitting multiple sclerosis and effects of anti‐CD20 therapy.

Saved in:
Bibliographic Details
Title: CD11c+ B cells in relapsing–remitting multiple sclerosis and effects of anti‐CD20 therapy.
Authors: El Mahdaoui, Sahla1 (AUTHOR) sahla.el.mahdaoui.01@regionh.dk, Hansen, Marie Mathilde1 (AUTHOR), von Essen, Marina Rode1 (AUTHOR), Hvalkof, Victoria Hyslop1 (AUTHOR), Holm Hansen, Rikke1 (AUTHOR), Mahler, Mie Reith1 (AUTHOR), Jennum, Poul2,3 (AUTHOR), Sellebjerg, Finn1,3 (AUTHOR), Romme Christensen, Jeppe1 (AUTHOR)
Source: Annals of Clinical & Translational Neurology. Apr2024, Vol. 11 Issue 4, p926-937. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23289503
DOI:10.1002/acn3.52009